Range Low Price High Price Comment
30 days $14.90 $17.25 Wednesday, 1st May 2024 VRNA stock ended at $15.22. This is 1.49% less than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 3.49% from a day low at $15.20 to a day high of $15.73.
90 days $14.90 $19.10
52 weeks $11.83 $23.81

Historical Verona Pharma plc prices

Date Open High Low Close Volume
Sep 26, 2023 $16.64 $16.90 $16.43 $16.49 146 802
Sep 25, 2023 $16.67 $16.79 $16.38 $16.56 220 853
Sep 22, 2023 $16.85 $17.15 $16.57 $16.57 411 471
Sep 21, 2023 $16.81 $17.66 $16.61 $16.73 292 951
Sep 20, 2023 $17.27 $17.37 $16.80 $16.94 193 617
Sep 19, 2023 $17.21 $17.77 $16.90 $17.24 258 492
Sep 18, 2023 $17.59 $17.79 $17.09 $17.17 174 702
Sep 15, 2023 $18.09 $18.13 $17.56 $17.61 252 570
Sep 14, 2023 $18.33 $18.74 $17.76 $18.15 205 837
Sep 13, 2023 $19.88 $19.88 $18.15 $18.30 378 499
Sep 12, 2023 $19.36 $20.04 $19.16 $19.87 165 212
Sep 11, 2023 $19.84 $20.30 $19.36 $19.41 506 261
Sep 08, 2023 $19.22 $20.07 $19.19 $19.66 172 387
Sep 07, 2023 $19.15 $19.43 $18.93 $19.22 334 795
Sep 06, 2023 $19.57 $19.99 $19.18 $19.27 286 190
Sep 05, 2023 $19.41 $19.69 $19.32 $19.51 274 842
Sep 01, 2023 $19.56 $20.05 $19.29 $19.40 153 791
Aug 31, 2023 $18.63 $19.74 $18.45 $19.43 235 241
Aug 30, 2023 $18.52 $18.67 $17.79 $18.50 513 310
Aug 29, 2023 $19.45 $19.83 $18.74 $18.74 161 327
Aug 28, 2023 $19.67 $20.03 $19.40 $19.45 93 314
Aug 25, 2023 $19.56 $20.17 $19.01 $19.52 146 379
Aug 24, 2023 $19.80 $19.81 $19.28 $19.45 228 222
Aug 23, 2023 $19.29 $19.76 $19.03 $19.70 148 259
Aug 22, 2023 $19.07 $19.32 $18.95 $19.15 140 605
Click to get the best stock tips daily for free!

About Verona Pharma plc

Verona Pharma plc Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the ... VRNA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT